Literature DB >> 17720031

Antipsychotic medication adherence in schizophrenia.

Matthew J Byerly1, Paul A Nakonezny, Emmeline Lescouflair.   

Abstract

For individuals who have schizophrenia, adherence to medication is often poor, and stopping medication often has serious consequences. This article provides an update on recent literature regarding the frequency, clinical and social impact, and clinical correlates of nonadherence to antipsychotic medication in schizophrenia. The authors then review published trials of interventions to improve adherence in schizophrenia.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17720031     DOI： 10.1016/j.psc.2007.04.002

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  44 in total

1.  Consumer empowerment and self-advocacy outcomes in a randomized study of peer-led education.

Authors:  Susan A Pickett; Sita M Diehl; Pamela J Steigman; Joy D Prater; Anthony Fox; Patricia Shipley; Dennis D Grey; Judith A Cook
Journal:  Community Ment Health J       Date:  2012-03-30

2.  A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.

Authors:  Paul A Nakonezny; Carroll W Hughes; Taryn L Mayes; Kathryn H Sternweis-Yang; Betsy D Kennard; Matthew J Byerly; Graham J Emslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-10       Impact factor: 2.576

Review 3.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 4.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

5.  Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.

Authors:  Meng-Yun Wu; Jae Kennedy; Lawrence J Cohen; Chi-Chuan Wang
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

6.  Cognitive behavior therapy for people with schizophrenia.

Authors:  Ann K Morrison
Journal:  Psychiatry (Edgmont)       Date:  2009-12

7.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

8.  Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram
Journal:  Cost Eff Resour Alloc       Date:  2011-05-13

9.  Development and Feasibility Testing of a Smartphone Intervention to Improve Adherence to Antipsychotic Medications.

Authors:  Julie Kreyenbuhl; Elizabeth J Record; Seth Himelhoch; Melanie Charlotte; Jessica Palmer-Bacon; Lisa B Dixon; Deborah R Medoff; Lan Li
Journal:  Clin Schizophr Relat Psychoses       Date:  2016-07-25

10.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.